Ultrasound-guided Transverses Abdominis Plane Block in Inguinal Herniorrhaphy: Randomized Controlled Clinical Trial
1 other identifier
interventional
40
1 country
2
Brief Summary
Acute postoperative pain is one of the most important centers of therapeutic attention in postoperative phase of any procedure. It is a complex entity that requires a multiple intervention to be treated and, depending on the intervened surgical site, it has different approaches. Despite attempts to reduce postoperative pain by implementing management protocols, rates of pain prevalence from moderate acute to severe pain are still reported as high as 50% in the first 24 postoperative hours. Among the surgeries that report greater intensity of postoperative pain is open inguinal Herniorrhaphy. That is why several techniques have been described for the management of acute pain in this surgery postoperative, among which PAT blocking has shown to be beneficial in some studies. However, some reports question its usefulness but with the emergence of ultrasound-guided techniques for its realization, interest in this blockage has grown back. This study aims to demonstrate the utility of the PAT blocking in the management of acute pain of pre-peritoneal inguinal herniorrhaphy with mesh.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for phase_4
Started Nov 2014
Shorter than P25 for phase_4
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2014
CompletedFirst Submitted
Initial submission to the registry
November 17, 2014
CompletedFirst Posted
Study publicly available on registry
November 24, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2015
CompletedNovember 24, 2014
November 1, 2014
8 months
November 17, 2014
November 20, 2014
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Postoperative acute pain measured by the visual analog scale (VAS) from 1-10 with 1 being the lowest and 10 the highest intensity after one hour of anesthesia suspension.
1 hour after the suspension of anesthesia
Secondary Outcomes (5)
Opioid Consumption 1
1 hour after the suspension of anesthesia
Adverse reactions 1
1 hour after the suspension of anesthesia
Postoperative acute pain 2
24 hours after the suspension of anesthesia
Adverse reactions 2
24 hours after the suspension of anesthesia
Opioid Consumption 2
24 hours after the suspension of anesthesia
Study Arms (2)
TAP block with Bupivacaine at 0.25%
EXPERIMENTALIntervention: Injection of local anesthetics in the transverses abdominal plane
Placebo saline solution
PLACEBO COMPARATORPlacebo: Injection of saline solution in the transverses abdominal plane
Interventions
Application of 20 mL of local anesthetic bupivacaine at 0.25% in the transverse abdominis plane (TAP) under ultrasound guidance. This area (TAP) is between the anterior fascia of the transverse abdominal muscle and the posterior fascia of the internal oblique muscle, through which the thoracic nerve fibers and a portion of the first lumbar pass. This intervention will be done 10 minutes before conducting the ipsilateral inguinal herniorrhaphy in a single application.
Application of 20 mL of saline solution in the transverse abdominis plane (TAP).
Eligibility Criteria
You may qualify if:
- Patients over 18 years attending Servicios Especiales de Salud (SES) Hospital of Caldas and Santa Sofia Hospital for inguinal hernia surgery.
- Physical status classification of the American Society of Anesthesiologists (ASA) (ASA I: healthy patient with no history or comorbidity and ASA II patients with compensated systemic disease).
- Acceptance to complete the informed consent.
You may not qualify if:
- Bilateral inguinal hernia.
- Allergy to drugs used in the study protocol (propofol, remifentanil, dipyrone, Dexamethasone, Tramadol, Morphine, Bupivacaine, Cephalexin, Cefazolin, Lidocaine, Sevoflurane, Chlorhexidine, Adrenaline, Naproxen, Acetaminophen)
- Lack of communication with the patient
- Inadequate social support network and interaction with the physician.
- Spinal Anesthesia
- Herniorrhaphy without mesh.
- Pregnancy
- Abuse of psychoactive substances.
- Daily consumption of opioids.
- Consumption of analgesics during the last 24 hours prior to surgery.
- Infection at the incision site
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Hospital Departamental Universitario Santa Sofía de Caldas
Manizales, Caldas Department, 170001, Colombia
SES Hospital de Caldas
Manizales, Caldas Department, 170001, Colombia
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Oscar D Aguirre Ospina, Specialist
Universidad de Caldas
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- phase 4
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Master in Business Administration
Study Record Dates
First Submitted
November 17, 2014
First Posted
November 24, 2014
Study Start
November 1, 2014
Primary Completion
July 1, 2015
Study Completion
October 1, 2015
Last Updated
November 24, 2014
Record last verified: 2014-11